TABLE 1.

Microbiological study results across different patient groups and clusters within two study periods

Patient group	No. (%) in 2017			No. (%) in 2018
	Total	Positive	Negative	Total	Positive	Negative
Outpatients
Total	205 (100)	57 (27.8)	148 (72.2)	351 (100)	239 (68.1)	112 (31.9)
Pediatric	108 (52.7)	49 (23.9)	59 (28.8)	224 (63.8)	190 (54.1)	34 (9.7)
Immunocompetent	108 (52.7)	49 (23.9)	59 (28.8)	223 (63.5)	189 (53.8)	34 (9.7)
Immunosuppressed	0 (0)	0 (0)	0 (0)	1 (0.3)	1 (0.3)	0 (0)
Adults (<65 yrs)	65 (31.7)	6 (2.9)	59 (28.8)	87 (24.8)	39 (11.1)	48 (13.7)
Immunocompetent	64 (31.2)	6 (2.9)	58 (28.3)	86 (24.5)	38 (10.8)	48 (13.7)
Immunosuppressed	1 (0.5)	0 (0)	1 (0.5)	1 (0.3)	1 (0.3)	0 (0)
Elderly (>65 yrs)	32 (15.6)	2 (1.0)	30 (14.6)	40 (11.4)	10 (2.8)	30 (8.5)
Immunocompetent	31 (15.1)	2 (1.0)	29 (14.1)	39 (11.1)	10 (2.8)	29 (8.3)
Immunosuppressed	1 (0.5)	0 (0)	1 (0.5)	1 (0.3)	0 (0)	1 (0.3)
Hospitalized patients
Total	302 (100)	105 (34.8)	197 (65.2)	478 (100)	283 (59.2)	195 (40.8)
Pediatric	118 (39.1)	68 (22.5)	50 (16.6)	150 (31.4)	115 (24.1)	35 (7.3)
Immunocompetent	76 (25.2)	64 (21.2)	12 (4.0)	114 (23.8)	107 (22.4)	7 (1.5)
Immunosuppressed	42 (13.9)	4 (1.3)	38 (12.6)	36 (7.5)	8 (1.7)	28 (5.9)
Adults (<65 yrs)	112 (37.1)	27 (8.9)	85 (28.1)	189 (39.5)	106 (22.2)	83 (17.4)
Immunocompetent	59 (19.5)	23 (7.6)	36 (11.9)	113 (23.6)	80 (16.7)	33 (6.9)
Immunosuppressed	53 (17.5)	4 (1.3)	49 (16.2)	76 (15.9)	26 (5.4)	50 (10.5)
Elderly (>65 yrs)	72 (23.8)	10 (3.3)	62 (20.5)	139 (29.1)	62 (13.0)	77 (16.1)
Immunocompetent	33 (10.9)	8 (2.6)	25 (8.3)	75 (15.7)	48 (10.0)	27 (5.6)
Immunosuppressed	39 (12.9)	2 (0.7)	37 (12.3)	64 (13.4)	14 (2.9)	50 (10.5)